Understanding treatment use after leaving opioid addiction programs
Treatment Utilization During Community Reentry of Opioid Use Disorder Inpatients
This study looks at how people with opioid use disorder get help after leaving treatment programs and aims to find ways to better support them during the risky time right after they return home.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rhode Island NIH-funded |
| Lab location | 1 site (Kingston, United States) |
| Project ID | NIH-10997506 on NIH RePORTER |
What this research studies
This research investigates how individuals with opioid use disorder (OUD) utilize treatment services after returning to their communities from residential programs. It focuses on the critical period following discharge, where the risk of relapse and overdose is highest. By using advanced methods like ecological momentary assessment and machine learning, the study aims to identify factors that influence treatment engagement during this vulnerable time. The goal is to improve continuity of care and support recovery outcomes for individuals transitioning back to their communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are transitioning from residential treatment for opioid use disorder back to their communities.
Not a fit: Patients who are not currently undergoing treatment for opioid use disorder or who are not in the re-entry phase may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better support systems for individuals recovering from opioid use disorder, reducing the risk of relapse and overdose.
How similar studies have performed: Other research has shown success in using similar approaches to improve treatment engagement and outcomes for individuals with substance use disorders.
Where this research is happening
Kingston, United States
- University of Rhode Island — Kingston, United States (Active)
Researchers
- Principal investigator: Newberger, Noam — University of Rhode Island
- Study coordinator: Newberger, Noam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.